Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation

BACKGROUND AIMS: Clinical trials for therapeutic angiogenesis use blood- or bone marrow-derived hematopoietic cells, endothelial progenitor cells (EPC) and mesenchymal stromal cells (MSC) for vascular regeneration. Recently concerns have emerged that all three cell types could also contribute to ath...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: ROHDE, EVA, SCHALLMOSER, KATHARINA, REINISCH, ANDREAS, HOFMANN, NICOLE A., PFEIFER, THOMAS, FRÖHLICH, ELEONORE, RECHBERGER, GERALD, LANZER, GERHARD, KRATKY, DAGMAR, STRUNK, DIRK
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2010
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3173858/
https://ncbi.nlm.nih.gov/pubmed/21128706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653249.2010.536214
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items